Investing in high blood pressure research: A national institutes of health perspective

Hypertension

Volumn 61, Issue 4, 2013, Pages 757-761

  Galis, Zorina S ^a   Thrasher, Terry ^a   Reid, Diane M ^a   Stanley, Dennis V ^a   Oh, Young S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II;

ARTERIAL STIFFNESS; ARTICLE; FUNDING; HUMAN; HYPERTENSION; INVESTMENT; NONHUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

BIOMEDICAL RESEARCH; BLOOD PRESSURE; HUMANS; HYPERTENSION; NATIONAL INSTITUTES OF HEALTH (U.S.); UNITED STATES;

EID: 84875210068     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.00770     Document Type: Article

References (41)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206-1252.
2. Roger VL, Go AS, Lloyd-Jones DM, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics:2012 update: a report from the American Heart Association. Circulation. 2012;125:e2-e220.
3. Sug Yoon S, Burt V. Hypertension among adults in the United States, 2009-2010, 2012; http://www.cdc.gov/nchs/data/databriefs/db107-pdf.
4. The National Institutes of Health (NIH) home page. www.nih.gov.
5. Glasser SP, Judd S, Basile J, Lackland D, Halanych J, Cushman M, Prineas R, Howard V, Howard G. Prehypertension, racial prevalence and its association with risk factors: Analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Am J Hypertens. 2011;24:194-199.
6. Pencina MJ, D'Agostino RB Sr, Larson MG, Massaro JM, Vasan RS. Predicting the 30-year risk of cardiovascular disease: the framingham heart study. Circulation. 2009;119:3078-3084.
7. The Framingham Heart Study. Cardiovascular disease (30-year risk). http://www.framinghamheartstudy.org/risk/cardiovascular30.html.
8. Neal B, MacMahon S, Chapman N; Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet. 2000;356:1955-1964.
9. Mancia G, Laurent S, Agabiti-Rosei E, et al; European Society of Hypertension. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens. 2009;27:2121-2158.
10. NIH Launches Multicenter Clinical Trial to Test Blood Pressure Strategy. 2009; http://www.nhlbi.nih.gov/news/press-releases/2009/nih-launchesmulticenter- clinical-trial-to-test-blood-pressure-strategy.html.
11. The National Heart Lung and Blood Institute (NHLBI) home page http://www.nhlbi.nih-gov/.
12. National Institutes of Health. RePORT: Estimates of funding for various research, condition, and disease categories (RCDC). http://report.nih.gov/ categorical-spending-aspx.
13. National Institutes of Health (NIH). The NIH Map Viewer http://app.nihmaps..org.
14. Galis ZS, Hoots WK, Kiley JP, Lauer MS. On the value of portfolio diversity in heart, lung, and blood research. Circ Res. 2012;111:833-836.
15. National Institutes of Health (NIH). Types of NIH grant programs http://grants.nih.gov/grants/funding/funding-program.htm.
16. Lauer MS. Thought exercises on accountability and performance measures at the National Heart, Lung, and Blood Institute (NHLBI): an invited commentary for circulation research. Circ Res. 2011;108:405-409.
17. National Institutes of Health. Public Access Policy http://publicaccess. nih.gov/.
18. Cowley AW Jr, Nadeau JH, Baccarelli A, et al. Report of the National Heart, Lung, and Blood Institute Working Group on epigenetics and hypertension. Hypertension. 2012;59:899-905.
19. National Institutes of Health. Research project grants: new (type 1) awards and percentage to targeted research. http://report.nih.gov/NIHDatabook/ Charts/Default.aspx?showm=Y&chartId=25&catId.2.
20. National Heart, Lung, and Blood Institute. NHLBI Working Group. Target organ damage in hypertension. 2008; http://www.nhlbi.nih.gov/meetings/tod- hypertension.htm.
21. Kaess BM, Rong J, Larson MG, Hamburg NM, Vita JA, Levy D, Benjamin EJ, Vasan RS, Mitchell GF. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA. 2012;308:875-881.
22. Diao D, Wright JM, Cundiff DK, Gueyffier F. Pharmacotherapy for mild hypertension. Cochrane Database Syst Rev. 2012;8:CD006742.
23. Doumas M, Douma S. Renal sympathetic denervation: the jury is still out. Lancet. 2010;376:1878-1880.
24. KOMP Repository. The knock-out mouse project https://www.komp.org/.
25. National Institutes of Health. Knockout mouse phenotyping program (KOMP2). http://commonfund.nih.gov.KOMP2/.
26. National Center for Advancing Translational Sciences. Clinical and translational science awards (CTSA). http://www.ncats.nih.gov/research/cts/ctsa/ ctsa.html.
27. National Heart, Lung, and Blood Institute (NHLBI). Ancillary Studies in Clinical Trials request for applications. http://grants.nih.gov/grants/guide/ rfa-files/RFA-HL-13-003.html.
28. National Heart, Lung, and Blood Institute. Secondary Dataset Analyses in Heart, Lung, and Blood Diseases and Sleep Disorders request for applications. http://grants.nih.gov/grants/guide/pa-files/PAR-13-009.html.
29. Wikipedia. Reverse engineering. http://en.wikipedia.org/wiki/Reverse. engineering.
30. Agency for Healthcare Research Quality. Medical expenditures panel survey. 2012; http://www2.liu.edu/cwis/cwp/library/workshop/citama.htm.
31. National High Blood Pressure Education Program Available at: http://www.nhlbi.nih.gov/about/nhbpep/nhbp-pd.htm.
32. Cutler DM, Rosen AB, Vijan S. The value of medical spending in the United States, 1960-2000. N Engl J Med. 2006;355:920-927.
33. Research America Poll. http://www.researchamerica.org/poll.summary.
34. The Economist. This week's Economist/YouGov poll 2010; http://www.economist.com/blogs/democracyinamerica/2010/04/economistyougov. polling.
35. Lowrey A. The futility of budget cuts. 2010; http:// washingtonindependent.com/81684/the-futility-of-budget-cuts.
36. Dorsey ER, de Roulet J, Thompson JP, Reminick JI, Thai A, White- Stellato Z, Beck CA, George BP, Moses H III. Funding of US biomedical research, 2003-2008. JAMA. 2010;303:137-143.
37. Stony Brook University School of Journalism. Communicating science to the public. http://www.centerforcommunicatingscience.org/communicating-science-to- the-public/.
38. Center for Public Engagement with Science and Technology. Advancing Science, Serving Society. http://www.aaas.org/programs/centers.pe/.
39. Alda A. The Art of Science Communication 2010; http://www.youtube.com/ watch?v.UGo6pTcTgVw.
40. National Institutes of Health (NIH). NIH grantees win 2012 Nobel Prize in Chemistry. 2012; http://www.nhlbi.nih.gov/news/press-releases/2012/nih- grantees-win-2012-nobel-prize-in-chemistry.html.
41. National Institutes of Health (NIH). Impact of NIH-sponsored research http://www.nih.gov/about-impact/.